-
Awarded10/01/2025
-
Today16/02/2025
Utilities
- indicates text translated automatically in your browsing language
Open House discount agreements of the TK - announcements of the contracts with the start of the contract on 01.12.2024 Text automatically translated in your browsing language Automatically translated
With this announcement, the TK publishes all contracts in the ongoing procedures "Open-House Discount Contracts", "Open-House Biologics Discount Contracts" and "Open-House Original Discount Contracts" with a discount beginning on the date specified in the abbreviation. The aim of the TK's procedures is to conclude discount agreements with all suitable pharmaceutical companies. The following applies: Individual negotiations on contract contents are not conducted, uniform conditions apply. TK does not guarantee any exclusivity to individual contractual partners. Access to the open house procedures is possible at any time during the contract period. The non-exclusive rebate agreements concluded in TK's open-house procedure generally serve to bridge the period between the patent expiration of active ingredients, combinations of active ingredients or dosage forms, potency and the entry into force of exclusive rebate agreements. During the term of the contract, TK reserves the right to replace the non-exclusive open-house discount agreements with exclusive discount agreements that are concluded in the context of a call for tenders subject to antitrust procurement law. With the entry into force of the exclusive discount agreements, the open-house discount agreements end in compliance with the relevant legal and contractual provisions. According to TK's experience, exclusive rebate contracts generally enter into force eight to ten months after the publication of the corresponding notice of invitation to tender in the Supplement to the Official Journal of the European Union. The future contractors are invited to consult the Supplement to the Official Journal of the European Union on a regular basis in relation to these invitations to tender. For the content and conditions of the individual procedures and, where applicable, the participation of other health insurance funds, reference is made to the original notices of the respective procedure in the Supplement to the Official Journal of the EU (TED). All further information can be found in the respective participation and contract documents. The original notices of the open-house procedures and this notice do not concern the award of a public contract within the meaning of the Public Procurement Directive (2014/24/EC) or antitrust law. In order to provide the widest possible information to interested pharmaceutical companies, these notices shall be published in the Supplement to the Official Journal of the European Union. Information such as "open procedure" or similar is due to the requirements of the notice form and has no further meaning. This and the use of the medium "TED" do not imply any submission to procurement regulations, the validity of which is not prescribed by law or procurement regulations. This notice lists all contracts concluded whose discount starts on the date indicated in the abbreviation. The information under "Information about the winner" is irrelevant. The contracts concluded on the aforementioned date are all listed under "General Information" to ensure greater clarity. Text automatically translated in your browsing language Automatically translated
Postal address:
Town: Siehe im Feld "Allgemeine Informationen"
Postal code: 99999
Country:
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.